Holistic Cannabis Academy co-founder Laura Lagano interviewed the grandfather of modern cannabis research Raphael Mechoulam on his experience with the ancient plant and what’s next.

Holistic Cannabis Academy co-founder Laura Lagano interviewed the grandfather of modern cannabis research Raphael Mechoulam on his experience with the ancient plant and what’s next.

Raphael Mechoulam shares his insights about how medical cannabis works. He’s adamant that there need to be more studies and trials to get more questions  answers about the probably benefits of cannabis.

35 years ago Mechoulam and his team did a clinical trial with cannabidiol (CBD).  After testing on mice and seeing how it can help, they went on to treat humans and they were “amazed how good it was.”

“We found that out of the eight patients – eights patients that nothing was helping them anymore. Out of these eight patients, four had no attacks while they were given cannabidiol. Three patients had much less, and only one was not affected. That was 35 years ago.”

What has been happening for the past 35 years!

For over 30 years, nothing has happened since Mechoulam’s clinical trials. That is until parents caught wind of how it could help their children. This may be just the push that medical cannabis needs in order for clinical trials in the US to begin.

To learn more about the work of Raphael Mechoulam and clinical cannabis, read the full interview here.

Cannabidiol (CBD) could help individuals who suffer from anxiety, depression, and schizophrenia. But without clinical trials we don’t know the powerful effects CBD – a cannabinoid in cannabis – could have on the population. With various trials in countries such as Israel and Germany, it is time for the United States to take the leap and get started.

Want to learn more about the ins and outs of holistic cannabis and helping other’s navigate their healthcare decisions?  Then join us at the Holistic Cannabis Academy and let the learning begin!

 

Print Friendly, PDF & Email

Comments are closed.